FTSE Russell Analytics

content.title.value
FTSE Russell Analytics

PDF, 458.33KB, 4 pages

Download
Download

Share price analysis relative to sector and index performance.

Company tear sheet

content.image.label
Company tear sheet

PDF, 60.99KB, 7 pages

Download
Download

Full issuer details available in a single file ready for sharing.

Synairgen plc news

Show all news
Sort by
Show 20 news
151 results (20 showing)
HeadlineSourceDateTime
Synairgen appoints Gareth Walters, Ph.D. as CRO
Reach
13 October 2021
07:00:09
Reach 13.10.21 07:00:09
Holding(s) in Company
RNS
05 October 2021
11:25:07
RNS 05.10.21 11:25:07
Non-Executive Director Appointment
RNS
30 September 2021
07:02:07
RNS 30.09.21 07:02:07
Interim results
RNS
30 September 2021
07:00:12
RNS 30.09.21 07:00:12
Synairgen Notice of Interim Results
RNS
21 September 2021
07:00:10
RNS 21.09.21 07:00:10
Holding(s) in Company
RNS
10 September 2021
11:30:04
RNS 10.09.21 11:30:04
Exercise of Options and Total Voting Rights
RNS
12 August 2021
16:12:17
RNS 12.08.21 16:12:17
Holding(s) in Company
RNS
06 August 2021
12:21:49
RNS 06.08.21 12:21:49
Holding(s) in Company
RNS
29 June 2021
16:28:07
RNS 29.06.21 16:28:07
Result of AGM
RNS
18 June 2021
10:29:14
RNS 18.06.21 10:29:14
Grant of Options
RNS
07 June 2021
07:00:12
RNS 07.06.21 07:00:12
Notice of AGM
RNS
25 May 2021
16:28:54
RNS 25.05.21 16:28:54
Results of in vitro studies
Reach
24 May 2021
07:00:08
Reach 24.05.21 07:00:08
Full Year Results
RNS
12 May 2021
07:00:04
RNS 12.05.21 07:00:04
Home Cohort data of SG016 Phase II trial
RNS
30 April 2021
07:00:07
RNS 30.04.21 07:00:07
Holding(s) in Company
RNS
16 April 2021
16:37:09
RNS 16.04.21 16:37:09
Holding(s) in Company
RNS
15 April 2021
11:44:17
RNS 15.04.21 11:44:17
Holding(s) in Company
RNS
06 April 2021
16:36:16
RNS 06.04.21 16:36:16
Dosing commenced in US ACTIV-2 trial
RNS
15 February 2021
07:00:07
RNS 15.02.21 07:00:07
Inclusion in US ACTIV-2 trial
RNS
25 January 2021
07:00:07
RNS 25.01.21 07:00:07